U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090161) titled 'Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension' on July 22.
Brief Summary: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension
Study Start Date: July 28
Study Type: INTERVENTIONAL
Condition:
Hypertension
Uncontrolled Hypertension
Intervention:
DRUG: iloperidone
iloperidone
DRUG: Placebo
placebo comparator
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vanda Pharmaceuticals
Published by HT Digital Content Services with permissi...